GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (NEOE:MYCO) » Definitions » Sale Of Business

Mydecine Innovations Group (NEOE:MYCO) Sale Of Business : C$0.00 Mil (TTM As of Sep. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Mydecine Innovations Group Sale Of Business?

Mydecine Innovations Group's sale of business for the three months ended in Sep. 2023 was C$0.00 Mil. It means Mydecine Innovations Group gained C$0.00 Mil from selling business. Mydecine Innovations Group's sale of business for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Jun. 2023 ), Mydecine Innovations Group gained the same money from selling business in Sep. 2023 (C$0.00 Mil).


Mydecine Innovations Group Sale Of Business Historical Data

The historical data trend for Mydecine Innovations Group's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Sale Of Business Chart

Mydecine Innovations Group Annual Data
Trend Dec13 Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - 0.50 - -

Mydecine Innovations Group Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Mydecine Innovations Group Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mydecine Innovations Group Sale Of Business Related Terms

Thank you for viewing the detailed overview of Mydecine Innovations Group's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Mydecine Innovations Group (NEOE:MYCO) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (NEOE:MYCO) Headlines

No Headlines